Singapore markets closed

Straits Times Index
3,306.02
+6.02(+0.18%)
Nikkei
38,596.47
-36.55(-0.09%)
Hang Seng
18,028.52
-306.80(-1.67%)
FTSE 100
8,237.72
-34.74(-0.42%)
Bitcoin USD
64,421.89
+178.34(+0.28%)
CMC Crypto 200
1,351.86
-8.46(-0.62%)

BIIB Oct 2024 110.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

117.72

0.00

(0.00%)

At close: 02:58PM EDT

Loading interactive chart…

Zacks
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Ionis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The companies signed a similar deal last year granting Otsuka rights to market the drug in Europe.
Zacks
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.
Zacks
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.